Core Laboratories (CLB) News Today → get a piece of the profit from this land (From True Market Insiders) (Ad) Free CLB Stock Alerts $18.04 +0.14 (+0.78%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 17 at 11:22 PM | marketbeat.comCore Laboratories Inc. (NYSE:CLB) Sees Large Growth in Short InterestCore Laboratories Inc. (NYSE:CLB - Get Free Report) saw a large increase in short interest in April. As of April 30th, there was short interest totalling 6,610,000 shares, an increase of 10.7% from the April 15th total of 5,970,000 shares. Based on an average daily volume of 398,800 shares, the short-interest ratio is currently 16.6 days. Currently, 14.2% of the shares of the stock are sold short.May 16 at 4:30 AM | americanbankingnews.comCore Laboratories (NYSE:CLB) Stock Passes Above Two Hundred Day Moving Average of $16.96May 12, 2024 | marketbeat.comPartnership Wealth Management LLC Makes New $2.20 Million Investment in Core Laboratories Inc. (NYSE:CLB)Partnership Wealth Management LLC bought a new position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 124,379 shares of the oil and gas company's stock, valued at approximately $2May 8, 2024 | americanbankingnews.comCore Laboratories Inc. (NYSE:CLB) Given Average Rating of "Reduce" by BrokeragesMay 6, 2024 | marketbeat.comCore Laboratories Inc. (NYSE:CLB) Shares Acquired by Fisher Asset Management LLCFisher Asset Management LLC lifted its stake in Core Laboratories Inc. (NYSE:CLB - Free Report) by 21.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 753,555 shares of the oil and gas company's stock after purchasing an additional 133,May 3, 2024 | marketbeat.comCore Laboratories Inc. (NYSE:CLB) Shares Sold by Van ECK Associates CorpVan ECK Associates Corp lowered its stake in Core Laboratories Inc. (NYSE:CLB - Free Report) by 17.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 586,432 shares of the oil and gas company's stock after selling 121,436 shares during the quarter. VaMay 2, 2024 | finance.yahoo.comCore Laboratories Inc.'s (NYSE:CLB) CEO Compensation Is Looking A Bit Stretched At The MomentApril 30, 2024 | finance.yahoo.comCore Laboratories N.V. (NYSE:CLB) Q1 2024 Earnings Call TranscriptApril 29, 2024 | marketbeat.comCore Laboratories Inc. (NYSE:CLB) Short Interest UpdateCore Laboratories Inc. (NYSE:CLB - Get Free Report) was the recipient of a large decrease in short interest in April. As of April 15th, there was short interest totalling 5,970,000 shares, a decrease of 9.4% from the March 31st total of 6,590,000 shares. Approximately 12.9% of the shares of the company are short sold. Based on an average trading volume of 453,200 shares, the short-interest ratio is currently 13.2 days.April 29, 2024 | finance.yahoo.comThese Return Metrics Don't Make Core Laboratories (NYSE:CLB) Look Too StrongApril 27, 2024 | seekingalpha.comCore Laboratories Inc. (CLB) Q1 2024 Earnings Call TranscriptApril 26, 2024 | marketbeat.comCore Laboratories (NYSE:CLB) Price Target Raised to $18.00Stifel Nicolaus raised their price objective on Core Laboratories from $17.00 to $18.00 and gave the company a "hold" rating in a research note on Friday.April 26, 2024 | marketbeat.comCore Laboratories Inc. (NYSE:CLB) to Issue Quarterly Dividend of $0.01Core Laboratories Inc. (NYSE:CLB) announced a quarterly dividend on Wednesday, April 24th. Investors of record on Monday, May 6th will be paid a dividend of 0.01 per share by the oil and gas company on Tuesday, May 28th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.23%. The ex-dividend date is Friday, May 3rd.April 26, 2024 | finance.yahoo.comQ1 2024 Core Laboratories Inc Earnings CallApril 25, 2024 | finanznachrichten.deCore Laboratories Inc: Core Lab Reports First Quarter 2024 ResultsApril 25, 2024 | marketbeat.comCore Laboratories (NYSE:CLB) Shares Gap Up on Earnings BeatCore Laboratories (NYSE:CLB) Shares Gap Up After Earnings BeatApril 25, 2024 | msn.comCore Laboratories declares $0.01 dividendApril 25, 2024 | investorplace.comCLB Stock Earnings: Core Laboratories Beats EPS, Beats Revenue for Q1 2024April 24, 2024 | msn.comCore Laboratories Non-GAAP EPS of $0.07 misses by $0.08, revenue of $129.6M beats by $5.14MApril 24, 2024 | marketbeat.comCore Laboratories (NYSE:CLB) Updates Q2 2024 Earnings GuidanceCore Laboratories (NYSE:CLB) updated its second quarter 2024 earnings guidance. The company provided EPS guidance of 0.190-0.230 for the period, compared to the consensus estimate of 0.210. The company also issued revenue guidance of $130.0 millionillion-$136.0 millionillion, compared to the consensus estimate of $130.1 millionillion.April 24, 2024 | prnewswire.comCORE LAB REPORTS FIRST QUARTER 2024 RESULTSApril 19, 2024 | marketbeat.comResearch Analysts Offer Predictions for Core Laboratories Inc.'s Q1 2024 Earnings (NYSE:CLB)Core Laboratories Inc. (NYSE:CLB - Free Report) - Stock analysts at Zacks Research cut their Q1 2024 earnings estimates for shares of Core Laboratories in a research note issued to investors on Thursday, April 18th. Zacks Research analyst T. Saha now expects that the oil and gas company will postApril 18, 2024 | marketbeat.comCore Laboratories (NYSE:CLB) Trading 5% Higher Core Laboratories (NYSE:CLB) Shares Up 5%April 17, 2024 | finance.yahoo.comEarnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to DeclineApril 15, 2024 | marketbeat.comCore Laboratories Inc. (NYSE:CLB) Short Interest Up 10.0% in MarchCore Laboratories Inc. (NYSE:CLB - Get Free Report) was the target of a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 6,590,000 shares, a growth of 10.0% from the March 15th total of 5,990,000 shares. Based on an average daily volume of 474,000 shares, the days-to-cover ratio is currently 13.9 days. Currently, 14.2% of the company's shares are sold short.April 15, 2024 | marketbeat.comCore Laboratories (NYSE:CLB) Price Target Cut to $16.00 by Analysts at Bank of AmericaBank of America lowered their price target on Core Laboratories from $17.00 to $16.00 and set an "underperform" rating for the company in a research report on Monday.April 8, 2024 | msn.comHC asks Centre, NABL to reply to PIL on labs illegally collecting samples, giving false reportsApril 4, 2024 | msn.comState-of-the-art specialist school to be in North-East for students with autismApril 3, 2024 | marketbeat.comVanguard Group Inc. Sells 76,917 Shares of Core Laboratories Inc. (NYSE:CLB)Vanguard Group Inc. lowered its holdings in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 1.4% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 5,360,112 shares of the oil and gas company's stock after selling 76,917 shares durinMarch 28, 2024 | msn.comGovernor Abbott appoints Ronnie Keister to Texas County And District Retirement System Board Of TrusteesMarch 28, 2024 | msn.comThese 2024 irons improve toe misses, according to robot testingMarch 28, 2024 | msn.comLDCC holds ribbon cutting for new Medical Technicians LaboratoryMarch 28, 2024 | msn.comLabcorp Expands Diagnostic Reach With Strategic Deal For Select Assets Of BioReference HealthMarch 28, 2024 | marketbeat.comFY2025 Earnings Estimate for Core Laboratories Inc. (NYSE:CLB) Issued By Zacks ResearchCore Laboratories Inc. (NYSE:CLB - Free Report) - Investment analysts at Zacks Research lifted their FY2025 earnings per share estimates for shares of Core Laboratories in a note issued to investors on Tuesday, March 26th. Zacks Research analyst T. Saha now anticipates that the oil and gas companMarch 26, 2024 | finance.yahoo.comCORE LABORATORIES' FIRST QUARTER 2024 WEBCAST AT 7:30 A.M. CDT / 8:30 A.M. EDT ON APRIL 25, 2024March 21, 2024 | finance.yahoo.comShareholders in Core Laboratories (NYSE:CLB) are in the red if they invested five years agoMarch 18, 2024 | finance.yahoo.comCore Laboratories Inc.: Growing International and Offshore Markets Continue to Boost Demand for Core Labs' ServicesMarch 15, 2024 | ca.finance.yahoo.comQ4 2023 Evoke Pharma Inc Earnings CallMarch 15, 2024 | theguardian.comAngela Rayner says she wants to see Diane Abbott get Labour whip restored – as it happenedMarch 14, 2024 | msn.comLow-cost lab works helps everyone “know their numbers”March 11, 2024 | finance.yahoo.comCore Laboratories (CLB) Fell on Mixed Earnings ResultsMarch 7, 2024 | marketbeat.comBrokers Issue Forecasts for Core Laboratories Inc.'s Q1 2024 Earnings (NYSE:CLB)Core Laboratories Inc. (NYSE:CLB - Free Report) - Investment analysts at Zacks Research dropped their Q1 2024 earnings per share estimates for shares of Core Laboratories in a research note issued to investors on Monday, March 4th. Zacks Research analyst T. Saha now forecasts that the oil and gasMarch 7, 2024 | marketbeat.comInvesco Ltd. Acquires 88,013 Shares of Core Laboratories Inc. (NYSE:CLB)Invesco Ltd. increased its holdings in Core Laboratories Inc. (NYSE:CLB - Free Report) by 25.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 436,459 shares of the oil and gas company's stock after purchaMarch 5, 2024 | marketbeat.comCore Laboratories Inc. (NYSE:CLB) Shares Acquired by Envestnet Asset Management Inc.Envestnet Asset Management Inc. lifted its stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 39.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 328,435 shares of the oil and gas company's stock afterMarch 3, 2024 | marketbeat.comAriel Investments LLC Has $217.62 Million Stock Holdings in Core Laboratories Inc. (NYSE:CLB)Ariel Investments LLC cut its holdings in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 5.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 9,063,718 shares of the oil and gFebruary 27, 2024 | finance.yahoo.comCore Laboratories (CLB) Fell Due to Weak US Land DrillingFebruary 23, 2024 | bizjournals.comLeadership shakeup at Yuga Labs after co-founder reclaims CEO roleFebruary 23, 2024 | msn.comUnifor reaches tentative deal with Jamieson Laboratories after three-week strikeFebruary 23, 2024 | marketbeat.comGendell Jeffrey L Purchases 44,953 Shares of Core Laboratories Inc. (NYSE:CLB)Gendell Jeffrey L raised its position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 59.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 119,953 shares of the oil and gas comFebruary 23, 2024 | marketbeat.comCore Laboratories (NYSE:CLB) Sets New 52-Week Low at $13.82Core Laboratories (NYSE:CLB) Reaches New 52-Week Low at $13.82 Get Core Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon Musk’s PRIME is Set to Shock the World (Ad)Must-See: Elon's New Invention is Absolutely Insane When you click here and see what Elon Musk’s new invention does…You will NOT believe it. But Elon just tested this in a real human… And the result was mind-blowing. Click here for the full story… CLB Media Mentions By Week CLB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLB News Sentiment▼1.470.60▲Average Oils/Energy News Sentiment CLB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLB Articles This Week▼33▲CLB Articles Average Week Get Core Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NESR News PUMP News PFHC News ACDC News NGS News RNGR News RES News HLX News XPRO News OII News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CLB) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryMost important medical advance in 100 yearsThe Oxford ClubNext President (Not Trump. Not Biden.)The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Core Laboratories Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
